Last reviewed · How we verify
Pfizer-BioNTech COVID-19 vaccine — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Pfizer-BioNTech COVID-19 vaccine (Pfizer-BioNTech COVID-19 vaccine) — Respiralab.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pfizer-BioNTech COVID-19 vaccine TARGET | Pfizer-BioNTech COVID-19 vaccine | Respiralab | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pfizer-BioNTech COVID-19 vaccine CI watch — RSS
- Pfizer-BioNTech COVID-19 vaccine CI watch — Atom
- Pfizer-BioNTech COVID-19 vaccine CI watch — JSON
- Pfizer-BioNTech COVID-19 vaccine alone — RSS
Cite this brief
Drug Landscape (2026). Pfizer-BioNTech COVID-19 vaccine — Competitive Intelligence Brief. https://druglandscape.com/ci/pfizer-biontech-covid-19-vaccine. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab